OMX30 1 594 -0,9%  OMXH25 4 136 -1,7%  Bitcoin 6 322,34 0,8%  Dow 25 162 -0,5%  Nas 7 355 -1,2%  EUR 10,4448 0,0%  USD 9,1747 -0,3%  Olja 71,0 0,3%  Guld 1 174 0,3% 

Edwards Lifesciences Aktie

137,84USD 0,72USD 0,53%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Edwards Lifesciences Chart - 1 År - BTT

Fundamentala nyckeltal för Edwards Lifesciences

2017 2018e 2019e 2020e 2021e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 29,95 31,23 27,89 24,94 22,16
Resultat/aktie 3,80 4,67 5,23 5,85 6,59

Nyheter om Edwards Lifesciences Corp.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Edwards Lifesciences Corp.

ytterligare analyser

Edwards Lifesciences Peer Group

Edwards Lifesciences 137,84
0,5%
pagehit

Lägg till instrument

Vad tycker du?

Profil Edwards Lifesciences Corp.till bolagsprofilen

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Realtidskurs Edwards Lifesciences Corp.

Bid 137,84 USD Ask 144,36 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Edwards Lifesciences Corp. i USDPUSH CHART

Kurs 137,84 USD 0,72 0,53 %
Kurstid 21:59:59
Datum 15.08.2018
Öppning 136,21
Gårdagen 137,12
Dagshögsta 138,14
Dagslägsta 134,53
52 v. högsta 156,76
52 v. lägsta 100,20
52 v. perf.
Volym (Antal) 88 972
Börsvärde (SEK) 262,45 Mrd
Börsen
Kurs för 137,84 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 264,64 SEK.

Till aktien Edwards Lifesciences

Ticker
ISIN US28176E1082
Index S&P 500

Edwards Lifesciences Nyckeltal

Börsvärde i SEK 262,45 Mrd
Free float %
Antal aktier mio. 209,39
Cashflow/aktie i lokal valuta 4,63
Bokvärde/aktie i lokal valuta 14,20
60 dagar vola 26,33
PBV

Edwards Lifesciences Historiska kurser

2018-08-15 137,84 88 972
2018-08-14 137,12 36 469
2018-08-13 137,09 35 995
2018-08-10 138,13 45 372
2018-08-09 139,18 71 160